Sirtuin 1 modulation unlocks the therapeutic potential of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in calcific aortic valve stenosis
Cardiovasc Res. 2026 Sep 8:cvag199. doi: 10.1093/cvr/cvag199. Online ahead of print.ABSTRACTBACKGROUND: Calcific aortic valve stenosis (AS) affects 3% of older adults and lacks medical treatment. The deacetylase Sirtuin 1 (SIRT1) could be involved in many pathways linked to AS progression. Sodium-gl

